How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation
GoodRx Holdings Inc GDRX
$2.92
▼ -1.68%
($-0.05)
Open
$2.94
Prev Close
$2.97
Day Range
$2.88 – $3.01
52W Range
$1.77 – $5.81
Market Cap
$988.93M
P/E (TTM)
48.93
Beta
1.62
EPS (TTM)
$0.06
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-09-23 |
| Shares Out. | 338,680,000 |
| Website | investors.goodrx.com/ ↗ |
| Phone | 13026365401 |
GoodRx Holdings Inc is a publicly traded company under the ticker symbol GDRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-05-01)
📰 Latest News for GDRX
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
GoodRx Launches Its $14.99 Per Month Subscription Service, GoodRx Companion
3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026
GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade)
GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade)
3 Value Stocks That Fall Short
Trump Announces Discount Drug Pricing Expansion With Mark Cuban